TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
LBRX

LB Pharmaceuticals Inc

Healthcare · Biotechnology

43.00$ +1.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

LB Pharmaceuticals Inc (LBRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 313 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LBRX
Line item 2022 2023 2024 2025
21 46 34 313
21 46 29 308
21 15 23 250
21 43 28 295
50 80 128 12
0.5 2.6 8.1 7.4
0.5 0.7
0.2 1.4 2.3 2.1
24
-29 -34 -95 301
-35 -41 -104 -130
3.5 3.5 3.5 25

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?